Brief: Delcath Systems Inc Said A Vendor Inadvertently Published Staging Site To Reflect Possibility That U.S. FDA Might Approve Hepzato
Aug 4 (Reuters) - Delcath Systems Inc DCTH.O :
* DELCATH SYSTEMS INC - A VENDOR INADVERTENTLY PUBLISHED
STAGING
SITE TO REFLECT POSSIBILITY THAT U.S. FDA MIGHT APPROVE HEPZATO
* DELCATH SYSTEMS INC - TO DATE, CO HAS NOT RECEIVED
DECISION BY
FDA AS TO ITS APPROVAL OF HEPZATO AND TARGET PDUFA DATE REMAINS
AUGUST 14
Source text for Eikon: ID:
Further company coverage: DCTH.O
Recent news on Delcath Systems
See all newsBrief: Delcath Systems Highlights Clinical Program Presentations At Esmo Congress 2026 And Independent Data On Percutaneous Hepatic Perfusion In Liver-Dominant Metastatic Uveal Melanoma
Brief: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule
Delcath Systems Inc reports results for the quarter ended June 30 - Earnings Summary
Delcath Systems Q2 revenue rises, beats estimates
Delcath Systems Inc expected to post a loss of 9 cents a share - Earnings Preview